2 Flashcards

(50 cards)

1
Q

Best for ↑HDL + ↓Triglycerides

A

NIACIN (Vitamin B3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mechanism:
• ↓Fat breakdown → ↓Free fatty acids →↓VLDL (LDL precursor).

A

NIACIN (Vitamin B3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Side Effects:
• Flushing (take aspirin 30min before to reduce).
• Itching, nausea, hepatotoxicity (high doses).

Use:
• Combined with statins if HDL low.

A

NIACIN (Vitamin B3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

1st-line for High Triglycerides

Mechanism: Activate PPAR-α → ↑Lipoprotein lipase → ↓Triglycerides.

Side Effects:
• GI upset, gallstones, myopathy (avoid with statins).

Avoid in: Liver/kidney disease.

A

FIBRATES (Gemfibrozil, Fenofibrate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mechanism: Bind bile acids in gut → Liver uses cholesterol to make more bile → ↓LDL.

Drugs: Cholestyramine, Colesevelam.

Uses:
• Mild LDL reduction (add-on to statins).
• _______ also lowers glucose (Type 2 Diabetes).

Side Effects:
• GI issues (bloating, constipation).
• ↓Absorption of fat-soluble vitamins (A,D,E,K) + other drugs (warfarin, levothyroxine).

A

BILE ACID SEQUESTRANTS (Resins);

• Colesevelam also lowers glucose (Type 2 Diabetes).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanism: Blocks NPC1L1 in gut → ↓Cholesterol absorption.

Use:
• Add-on to statins (or if statin-intolerant).
• Mild LDL reduction alone.

Side Effects: Rare (diarrhea, fatigue).

A

EZETIMIBE (Cholesterol Absorption Inhibitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Definition:
Heart can’t pump enough blood → fluid buildup & fatigue.

A

HEART FAILURE (HF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cardinal Symptoms:

A

• Dyspnea (shortness of breath)
• Fatigue
• Fluid retention (edema, lung congestion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Problem:
Left ventricle weak/stiff

Key Feature:
Blood backs up into lungs → pulmonary edema (dyspnea

A

Left-Sided HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Problem: Right ventricle fails

Key Feature: Blood backs up into veins → leg swelling, liver congestion

A

Right-Sided HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Problem: Heart can’t contract well

Key Feature: Low ejection fraction (EF < 40%)

A

Systolic HF (HFrEF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Problem: Heart can’t relax/fill properly

Key Feature: Normal EF (≥50%) but stiff walls

A

Diastolic HF (HFpEF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Compensatory Mechanisms (Short-Term Help, Long-Term Harm):

Faster HR, vasoconstriction.

A

↑Sympathetic Activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Compensatory Mechanisms (Short-Term Help, Long-Term Harm):

→ Salt/water retention → ↑Blood volume.

A

RAAS Activation → Angiotensin II & Aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Compensatory Mechanisms (Short-Term Help, Long-Term Harm):

Thick/stiff walls → Worsens pumping

A

Heart Enlargement (Hypertrophy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug Therapy Goals

A

Improve heart contraction (↑CO)
Reduce heart workload (↓Preload & Afterload)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Reduce Heart Strain

A

UNLOADERS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

1st-line for HFrEF

MOA: Block Angiotensin II → ↓Vasoconstriction, ↓Aldosterone → ↓Afterload & ↓Fluid.

A

ACE Inhibitors (ACEIs) / ARBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lisinopril, Enalapril

A

ACEIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Losartan, Valsartan (if ACEI cough)

A

ARBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Side Effects:
• Dry cough (ACEIs), Hyperkalemia, Angioedema (rare).

A

ACE Inhibitors (ACEIs) / ARBs

22
Q

Spironolactone, Eplerenone

A

Aldosterone Antagonists

23
Q

MOA: Block aldosterone → ↓Fibrosis, ↓K⁺ loss.

Use: Advanced HF (NYHA III-IV) + HFrEF.

Side Effects: Hyperkalemia, Gynecomastia

A

Aldosterone Antagonists

24
Q

Gynecomastia Treatment

A

Spironolactone

25
MOA: Remove excess fluid → ↓Lung congestion, ↓Leg edema. Drugs: __________ (IV in acute HF), Hydrochlorothiazide. Side Effects: Low K⁺ (_________), Dehydration.
Diuretics (Loop > Thiazide); Furosemide; hypokalemia
26
Hydralazine + Nitrates
Vasodilators
27
Vasodilators: ↓Afterload (artery dilator).
Hydralazine
28
Vasodilators: ↓Preload (vein dilator).
Nitrates
29
Use: African-Americans (added to ACEI/ARB).
Vasodilators (Hydralazine + Nitrates)
30
↑Heart Contractility
INOTROPIC AGENTS
31
Cardiac Glycoside
Digoxin
32
INOTROPIC AGENTS: MOA: Inhibits Na⁺/K⁺ ATPase → ↑Ca²⁺ → Stronger beats. Use: HFrEF + Atrial Fibrillation (controls HR).
Digoxin (Cardiac Glycoside)
33
INOTROPIC AGENTS: Toxicity: • Nausea, Blurred/Yellow Vision (Xanthopsia), Arrhythmias. • Treat with: K⁺ correction, Digibind (Antidote).
Digoxin (Cardiac Glycoside)
34
Dobutamine, Dopamine
β-Adrenergic Agonists
35
INOTROPIC AGENTS: MOA: Stimulate β₁ receptors → ↑cAMP → ↑Ca²⁺ → ↑Contractility. Use: Acute HF (IV only, short-term). Side Effects: Tachycardia, Arrhythmias.
β-Adrenergic Agonists (Dobutamine, Dopamine)
36
INOTROPIC AGENTS: MOA: Blocks PDE3 → ↑cAMP → ↑Ca²⁺ → ↑Contractility + Vasodilation. Use: Acute HF (IV, if β-agonists fail). Side Effects: Arrhythmias, Hypotension.
Phosphodiesterase Inhibitors (Milrinone)
37
Source: Mast cells, basophils, stomach (ECL cells). Precursor: L-histidine → Histidine decarboxylase → Histamine.
HISTAMINE
38
Receptor Location: Bronchi, Blood vessels, Nerves Effect: - Bronchoconstriction - Vasodilation - Itching/Pain - ↑Capillary permeability (edema) Clinical Relevance: Allergy (antihistamines block H₁)
H₁
39
Receptor Location: Stomach (parietal cells) Effect:↑Gastric acid secretion Clinical Relevance: __________ (H₂ blockers like Famotidine)
H₂; GERD/PUD (H₂ blockers like Famotidine)
40
Receptor Location: CNS (presynaptic) Effect:↓Histamine release (feedback) Clinical Relevance: Less clinically targeted
H₃
41
Diphenhydramine, Promethazine (↑CNS effects, anticholinergic).
H₁ Antihistamines • 1st Gen (Sedating)
42
Fexofenadine, Loratadine (fewer side effects).
H₁ Antihistamines • 2nd Gen (Non-sedating)
43
Uses: Allergies, motion sickness, insomnia (1st gen).
H₁ Antihistamines
44
• Drugs: Famotidine (most potent), Ranitidine, Cimetidine. • Use: Reduce stomach acid (PUD, GERD). • Cimetidine SE: ________ (antiandrogenic), drug interactions (CYP inhibitor).
H₂ Blockers; Gynecomastia
45
Source: Enterochromaffin cells (GI), CNS, platelets. Precursor: L-tryptophan → Tryptophan hydroxylase → 5-HTP → 5-HT
SEROTONIN (5-HT)
45
Location: CNS (presynaptic) Effect:↓Serotonin release Drugs: Buspirone (partial agonist) Use: Anxiety
5-HT₁A
46
Location: CTZ (brainstem) Effect: Emesis (vomiting) Drugs: -setrons (Ondansetron) Use: Chemo-induced nausea
5-HT₃
47
Location: Blood vessels Effect: Vasoconstriction Drugs: Triptans (Sumatriptan) Use: Acute migraine
5-HT₁B/1D
48
Location: Smooth muscle, CNS Effect: Vaso/uterine contraction Drugs: Ergotamine (_______), Methysergide (________) Use: Migraine, PP hemorrhage
5-HT₂A; Ergotamine (agonist), Methysergide (antagonist)
49
Location: GI tract Effect: ↑Motility Drugs: Prucalopride (agonist) Use: Constipation, IBS